A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Eli Lilly and Company
Eli Lilly and Company
University of Wisconsin, Madison
Mayo Clinic
Merck Sharp & Dohme LLC
New York State Psychiatric Institute
Novartis
Henan Cancer Hospital
University Hospital, Angers
Beijing Chao Yang Hospital
Eli Lilly and Company
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Ascentage Pharma Group Inc.
International Food Policy Research Institute
Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud - IDCBIS
Center for Health Sciences, Serbia
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
University of California, Irvine
TICAROS Co., Ltd.
University of Pennsylvania
Nanfang Hospital, Southern Medical University
Institute of Hematology & Blood Diseases Hospital, China
Case Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Sun Yat-sen University
Universität Münster
Tel-Aviv Sourasky Medical Center
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
First Affiliated Hospital Xi'an Jiaotong University
University of Sfax
Tianjin Medical University Cancer Institute and Hospital
Peking University Cancer Hospital & Institute
ResMed
Centre hospitalier Henri Mondor d'Aurillac
Zhejiang Cancer Hospital
Drexel University
Sun Yat-sen University
Ruijin Hospital
Peking University People's Hospital
Jiangsu HengRui Medicine Co., Ltd.
Centre Hospitalier Saint Joseph Saint Luc de Lyon
XEME Biopharma Inc.